companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories












Company Directories & Business Directories

HARROW W D

BRANTFORD-Canada

Company Name:
Corporate Name:
HARROW W D
Company Title:  
Company Description:  
Keywords to Search:  
Company Address: 88 Nelson St,BRANTFORD,ON,Canada 
ZIP Code:
Postal Code:
N3T 
Telephone Number: 5197568780 
Fax Number:  
Website:
 
Email:
 
USA SIC Code(Standard Industrial Classification Code):
21021 
USA SIC Description:
ATTORNEYS 
Number of Employees:
 
Sales Amount:
 
Credit History:
Credit Report:
 
Contact Person:
 
Remove my name



copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)









Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Your Subject:
Your Comment or Review:
Security Code:



Previous company profile:
HART DENTAL LABORATORY INC
HARRYS CUSTOM TAILORING
HARRYS
Next company profile:
HARRIS, SANDRA J
HARRIS SANDRA J LAW OFFICE
HARRIS LAWREN S MEDICAL CLINIC DR










Company News:
  • Harrow Enters into Commercialization Agreement with Samsung Bioepis for . . .
    Harrow, Inc (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market
  • Products - Harrow
    Harrow owns an FDA-Registered 503B Outsourcing Facility and a patient-specific 503A pharmacy
  • Our History - Harrow
    Harrow’s history is a testament to resilience, collaboration, and bold thinking With a strategic plan in motion and a commitment to our core values, we are poised for an even brighter future – transforming eyecare and seting new standards of care for the ophthalmic pharmaceutical industry
  • Harrow
    Harrow, a growing leader in the North American ophthalmic pharmaceutical market, is dedicated to delivering innovative, accessible, and affordable eyecare solutions
  • Harrow to Report First Quarter 2025 Financial Results After Market . . .
    Harrow, Inc (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market
  • Harrow Expands VEVYE® Access for All Program to ImprimisRx’s Klarity-C . . .
    Harrow, Inc (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market
  • Harrow Appoints Mike Biega as Vice President of Investor Relations and . . .
    Harrow, Inc (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market
  • About - Harrow
    Harrow, a growing leader in the North American ophthalmic pharmaceutical market, is dedicated to delivering innovative, accessible, and affordable eyecare solutions
  • Harrow Announces Second Quarter 2024 Financial Results
    “The second quarter of 2024 marked a financial and operational turning point for Harrow, with revenues surging 46% compared to the same quarter last year and 42% over the previous quarter,” said Mark L Baum, Chief Executive Officer of Harrow
  • Harrow Announces New Appointments to its Board of Directors
    Harrow, Inc (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U S market




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer